Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Nature Genetics
|
April 6, 2004
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Stephan Züchner, Irina V Mersiyanova, Maria Muglia, et al.
Nature Reviews. Disease Primers
|
June 17, 2022
Genetic pain loss disorders
Annette Lischka, Petra Lassuthova, Arman Çakar, et al.
Neurogenetics
|
September 19, 2014
Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach
Magdalena Zimoń, Esra Battaloğlu, Yesim Parman, et al.
European Journal of Neurology
|
February 13, 2025
Disease Progression in Charcot-Marie-Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin-Related Proteins 2 and 13
Alessandro Bertini, Mary M Reilly, Chiara Pisciotta, et al.
American Journal of Human Genetics
|
October 24, 2003
Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy
Jan Senderek, Carsten Bergmann, Claudia Stendel, et al.
Brain : a Journal of Neurology
|
August 16, 2011
Genetic spectrum of hereditary neuropathies with onset in the first year of life
Jonathan Baets, Tine Deconinck, Els De Vriendt, et al.
Brain : a Journal of Neurology
|
June 22, 2017
MCM3AP in recessive Charcot-Marie-Tooth neuropathy and mild intellectual disability
Emil Ylikallio, Rosa Woldegebriel, Manuela Tumiati, et al.
JAMA
|
September 28, 2023
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy
Teresa Coelho, Wilson Marques, Noel R Dasgupta, et al.
Cell Reports
|
August 11, 2015
Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy
Claudia Gonzaga-Jauregui, Tamar Harel, Tomasz Gambin, et al.
The New England Journal of Medicine
|
July 5, 2018
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
David Adams, Alejandra Gonzalez-Duarte, William D O'Riordan, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Nature Genetics
|
April 6, 2004
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Stephan Züchner, Irina V Mersiyanova, Maria Muglia, et al.
Nature Reviews. Disease Primers
|
June 17, 2022
Genetic pain loss disorders
Annette Lischka, Petra Lassuthova, Arman Çakar, et al.
Neurogenetics
|
September 19, 2014
Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach
Magdalena Zimoń, Esra Battaloğlu, Yesim Parman, et al.
European Journal of Neurology
|
February 13, 2025
Disease Progression in Charcot-Marie-Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin-Related Proteins 2 and 13
Alessandro Bertini, Mary M Reilly, Chiara Pisciotta, et al.
American Journal of Human Genetics
|
October 24, 2003
Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy
Jan Senderek, Carsten Bergmann, Claudia Stendel, et al.
Brain : a Journal of Neurology
|
August 16, 2011
Genetic spectrum of hereditary neuropathies with onset in the first year of life
Jonathan Baets, Tine Deconinck, Els De Vriendt, et al.
Brain : a Journal of Neurology
|
June 22, 2017
MCM3AP in recessive Charcot-Marie-Tooth neuropathy and mild intellectual disability
Emil Ylikallio, Rosa Woldegebriel, Manuela Tumiati, et al.
JAMA
|
September 28, 2023
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy
Teresa Coelho, Wilson Marques, Noel R Dasgupta, et al.
Cell Reports
|
August 11, 2015
Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy
Claudia Gonzaga-Jauregui, Tamar Harel, Tomasz Gambin, et al.
The New England Journal of Medicine
|
July 5, 2018
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
David Adams, Alejandra Gonzalez-Duarte, William D O'Riordan, et al.
Page
of 7